Nuvectis Pharma (NVCT) SEC Filings & 10K Form

$6.15
-0.38 (-5.82%)
(As of 05/17/2024 ET)

Recent Nuvectis Pharma SEC Filings

DateFilerForm TypeView
05/15/2024
8:16 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
7:47 AM
Nuvectis Pharma (Issuer)
Shemesh Shay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
7:49 AM
Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
7:51 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
8:13 AM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:00 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
4:20 PM
Nuvectis Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2024
7:17 AM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
7:37 AM
Mosseri Marlio Charles (Filed by)
Nuvectis Pharma (Subject)
Form SC 13G/A
02/06/2024
7:47 AM
Nuvectis Pharma (Subject)
Pontifax Management 4 G.P. Ltd. (0001726334) (Filed by)
Form SC 13G
01/30/2024
8:01 PM
Nuvectis Pharma (Subject)
Peters Thomas Phineas (Filed by)
Form SC 13G/A
01/05/2024
3:30 PM
Nuvectis Pharma (Issuer)
Shemesh Shay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:31 PM
Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
7:39 AM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
6:45 AM
Nuvectis Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/12/2023
3:05 PM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
7:30 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
7:37 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
7:16 AM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2023
8:18 AM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2023
5:07 PM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2023
7:00 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2023
7:00 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
7:00 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/27/2023
5:52 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
3:45 PM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
3:45 PM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
5:30 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
5:30 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2023
7:06 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
7:34 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2023
7:30 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
7:30 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2023
7:00 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
7:03 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
7:04 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
6:45 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
7:00 AM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2023
7:45 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
7:45 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
7:45 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Guard Against the Coming Financial Upheaval (Ad)

America’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late.

You can stream it for free right here.
06/23/2023
7:59 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
7:42 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
7:25 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
7:15 AM
Hoberman Kenneth (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
7:16 AM
Kaplan Matthew L. (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
7:16 AM
Nuvectis Pharma (Issuer)
Oliviero James F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
3:45 PM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
5:46 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
8:28 PM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2023
7:00 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
8:29 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NVCT) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners